Nrc Health (NRC) Liabilities and Shareholders Equity (2010 - 2026)

Nrc Health's Liabilities and Shareholders Equity history runs 17 years deep, the most recent figure standing at $134.6 million for Q1 2026.

• In Q1 2026, Liabilities and Shareholders Equity changed 0.46% year-over-year to $134.6 million; the TTM figure through Mar 2026 stood at $546.5 million (up 5.39% YoY), while the FY2025 annual figure was $134.9 million, up 1.76% from the prior year.
• Liabilities and Shareholders Equity came in at $134.6 million for Q1 2026 at Nrc Health, roughly flat from $134.9 million in the prior quarter.
• In the past five years, Liabilities and Shareholders Equity ranged from a high of $153.2 million in Q1 2022 to a low of $119.1 million in Q2 2024.
• A 5-year average of $132.4 million and a median of $134.3 million in 2023 frame the typical range for Liabilities and Shareholders Equity.
• Across the five-year window, Liabilities and Shareholders Equity retreated 17.19% in 2022 and grew 18.71% in 2025, its largest moves.
• Nrc Health's Liabilities and Shareholders Equity stood at $130.5 million in 2022, then fell by 6.15% to $122.4 million in 2023, then increased by 8.25% to $132.5 million in 2024, then advanced by 1.76% to $134.9 million in 2025, then dropped by 0.24% to $134.6 million in 2026.
• According to Business Quant data, Liabilities and Shareholders Equity over the past three periods registered $134.6 million, $134.9 million, and $135.7 million for Q1 2026, Q4 2025, and Q3 2025 respectively.

Peer Comparison